Clinical trial

The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)

NCT06131268

Study summary

ClinicalTrials.gov

The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Venlafaxine Normalized identity: venlafaxine View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-03-01

PhasePHASE4

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Bipolar Affective Disorder, Currently Depressed, Moderateunresolved

Interventions

VenlafaxineDRUG · verified · RxNorm: venlafaxine

Sponsors & collaborators

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinicolead sponsor

Mapped research locations

MilanMI, Italy1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06131268 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.